Status:

TERMINATED

Establishment of Fibroid Tissue Bank

Lead Sponsor:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Conditions:

Leiomyoma

Fibroids

Eligibility:

FEMALE

21-80 years

Brief Summary

The purpose of this study is to collect information and tissue samples from women with uterine fibroids. The samples will be used to study genes, proteins and other substances in order to better under...

Detailed Description

The long term goal of this protocol is to create a repository of well-characterized fibroid (leiomyoma) tissues in order to gather information that will lead to improved understanding of uterine fibro...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Women aged 21-80 with uterine fibroids
  • Medically indicated hysterectomy, myomectomy or other surgery for uterine fibroids.
  • Samples from patients with unusual variants of fibroid disease (HLRCC, benign metastasizing leiomyomatosis) will be included. These samples may possibly not arise from the uterus proper, as the leiomyoma may have become located elsewhere in the body.
  • EXCLUSION CRITERIA:
  • Inability to give consent or understand the consent forms.
  • HIV-infected tissues will be excluded due to concern of equipment contamination.
  • Hepatitis-infected tissues will be excluded due to concern of equipment contamination.

Exclusion

    Key Trial Info

    Start Date :

    June 30 2008

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    September 1 2016

    Estimated Enrollment :

    43 Patients enrolled

    Trial Details

    Trial ID

    NCT00710346

    Start Date

    June 30 2008

    End Date

    September 1 2016

    Last Update

    June 1 2018

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland, United States, 20892